The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...
This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...
20, the FDA announced that the agency has approved Eli Lilly's Zepbound ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the ...
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...